Subscribe to our newsletter From Joe Burnett, President & CEO: This has been an incredible quarter of many ClearPoint firsts. I am delighted to share that we have now treated the first clinical trial patient…
Read More
Quarterly eNewsletter – September 2022 Edition
Quarterly eNewsletter – June 2022 Edition
Quarterly eNewsletter – March 2022 Edition
Quarterly eNewsletter – December 2021 Edition
Quarterly eNewsletter – September 2021 Edition